Cofactor Genomics
PrivateLast Round
Strategic
Dec 15, 2025
Total Funding Raised
$29.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cofactor Genomics is a biotechnology company that develops predictive diagnostic tests for immunotherapy using RNA-expression models and machine learning to characterize tumor microenvironments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cofactor Genomics Comparables
Compare Cofactor Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novigenix AI | 84% | |
| GeneCentric | 83% | |
| Genomic Expression, Inc. | 80% | |
Cofactor Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 15, 2025 | ||||
| Seed | Aug 2, 2023 | ||||
| Series A Extension | Dec 16, 2021 | ||||
| Series A | Sep 18, 2017 | ||||
| Seed | Aug 3, 2015 | ||||
Accelerator | Jul 31, 2015 |
Key People
Founding team and executive leadership
Cofactor Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| National Institute of Mental Health | Grant |
| iSelect Fund | Series A |
| Great Oaks Venture Capital | Seed |
| Founder Collective | Seed |
| Anorak Ventures | Seed |
| Khosla Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 33% MoM, reaching 3.6K.
- May 30, 2025
Presented on RNA and AI for Precision Medicine at the RNA Society's 30th Annual Meeting.
Cofactor Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cofactor Genomics's valuation, stock price, and market status.